Related Experiment Video
Updated: Feb 19, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Inappropriate Use of Homeostasis Model Assessment Cutoff Values for Diagnosing Insulin Resistance in Pediatric
Insights
Established insulin resistance cutoff values for pediatric patients are lacking scientific support. This review found common Homoeostasis Model Assessment (HOMA) values lack validation, impacting type 2 diabetes risk assessment in children.
Area of Science:
- Pediatric Endocrinology
- Metabolic Research
- Clinical Diagnostics
Background:
- Insulin resistance assessment in children is crucial for identifying type 2 diabetes mellitus risk.
- Homoeostasis Model Assessment (HOMA) is a common insulin resistance measure, but lacks established pediatric cutoff values.
- Existing pediatric HOMA cutoff values are widely used in research without clear validation.
Purpose of the Study:
- To evaluate the validity of Homoeostasis Model Assessment (HOMA) cutoff values used in pediatric research.
- To determine the evidential basis for commonly employed HOMA cutoff points in pediatric studies.
- To assess the reliability of HOMA as a diagnostic tool for insulin resistance in children.
Main Methods:
- Systematic review of pediatric studies published between January 2010 and December 2015.
- Screening of 298 articles for HOMA use in pediatric insulin resistance assessment.
- Analysis of citation history and references supporting HOMA cutoff values.
Main Results:
- 51 different HOMA cutoff values were identified across the analyzed studies.
- 85.6% of studies used fixed HOMA cutoff values, but only 28.2% provided supporting references.
- Many commonly used HOMA cutoff values lack validated evidence and are based on unverified sources.
Conclusions:
- There is a significant lack of evidence supporting the HOMA cutoff values currently used in pediatric research.
- The study underscores the need for rigorous validation of study design elements, including diagnostic criteria.
- Developing population-specific HOMA ranges is recommended to enhance its clinical utility in pediatric populations.
Background:
Assessing pediatric patients for insulin resistance is one way to identify those who are at a high risk of developing type 2 diabetes mellitus. The homoeostasis model assessment (HOMA) is a measure of insulin resistance based on fasting blood glucose and insulin levels. Although this measure is widely used in research, cutoff values for pediatric populations have not been established.
Objective:
To assess the validity of HOMA cutoff values used in pediatric studies published in peer-reviewed journals.
Methods:
Studies published from January 2010 to December 2015 were identified through MEDLINE. Initial screening of abstracts was done to select studies that were conducted in pediatric populations and used HOMA to assess insulin resistance. Subsequent full-text review narrowed the list to only those studies that used a specific HOMA score to diagnose insulin resistance. Each study was classified as using a predetermined fixed HOMA cutoff value or a cutoff that was a percentile specific to that population. For studies that used a predetermined cutoff value, the references cited to provide evidence in support of that cutoff were evaluated.
Results:
In the 298 articles analyzed, 51 different HOMA cutoff values were used to classify patients as having insulin resistance. Two hundred fifty-five studies (85.6%) used a predetermined fixed cutoff value, but only 72 (28.2%) of those studies provided a reference that supported its use. One hundred ten studies (43%) that used a fixed cutoff either cited a study that did not mention HOMA or provided no reference at all. Tracing of citation history indicated that the most commonly used cutoff values were ultimately based on studies that did not validate their use for defining insulin resistance.
Conclusion:
Little evidence exists to support HOMA cutoff values commonly used to define insulin resistance in pediatric studies. These findings highlight the importance of validating study design elements when training medical students and novice investigators. Using available data to generate population ranges for HOMA would improve its clinical utility.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Homeostatic Imbalance
However, sometimes these feedback loops fail,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational

